Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Depression × Duloxetine Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Depression 1

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 Therapeutics 1 Surveys and Questionnaires 1 Self Care 1 Forest Therapy 1 Educational Status 1 Duloxetine Hydrochloride 1 Abiraterone Acetate 1 4-amino-4'-hydroxylaminodiphenylsulfone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02443194 2015-12-03

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Tel-Aviv Sourasky Medical Center

Phase 3 Terminated

Depression, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡